Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers

BACKGROUND: Beta-blocker therapies for cardiovascular comorbidities are often withheld in patients with chronic obstructive pulmonary disease (COPD) due to potential adverse effects on airway obstruction. We carried out a post hoc analysis to determine the efficacy and safety of aclidinium in patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapman, Kenneth R., Wise, Robert A., Scirica, Benjamin M., Bhatt, Deepak L., Daoud, Sami Z., Lythgoe, Dan, Gil, Esther Garcia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532273/
https://www.ncbi.nlm.nih.gov/pubmed/34686204
http://dx.doi.org/10.1186/s12931-021-01861-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532273/
https://www.ncbi.nlm.nih.gov/pubmed/34686204
http://dx.doi.org/10.1186/s12931-021-01861-2

Ejemplares similares